000 01278 a2200337 4500
005 20250515110621.0
264 0 _c20080609
008 200806s 0 0 eng d
022 _a0004-8666
024 7 _a10.1111/j.1479-828X.2007.00816.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBujold, Emmanuel
245 0 0 _aAntibiotics for the prevention of preterm birth.
_h[electronic resource]
260 _bThe Australian & New Zealand journal of obstetrics & gynaecology
_cFeb 2008
300 _a124-5 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAnti-Infective Agents
_xadverse effects
650 0 4 _aAntibiotic Prophylaxis
650 0 4 _aClindamycin
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMeta-Analysis as Topic
650 0 4 _aMetronidazole
_xadverse effects
650 0 4 _aPregnancy
650 0 4 _aPregnancy Complications, Infectious
_xdrug therapy
650 0 4 _aPremature Birth
_xmicrobiology
650 0 4 _aVaginosis, Bacterial
_xdrug therapy
700 1 _aMorency, Anne-Maude
773 0 _tThe Australian & New Zealand journal of obstetrics & gynaecology
_gvol. 48
_gno. 1
_gp. 124-5
856 4 0 _uhttps://doi.org/10.1111/j.1479-828X.2007.00816.x
_zAvailable from publisher's website
999 _c17780341
_d17780341